|
⚲
|
| Keyboard |
| Christopher Gagliardi | |
|---|---|
| Firm | |
| Address | 610 Main Street Cambridge, MA 02139 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| AdvanCell Inc | 021-591090 | Director | 218.3 M of 315.0 M |
||
| I2O Therapeutics Inc | 021-495121 | Director | 3.5 M of 4.0 M |
||
| I2O Therapeutics Inc | 021-461414 | Director | 33.5 M of 42.0 M |
||
| I2O Therapeutics Inc | 021-430587 | Director | 2.3 M of 3.0 M |
||
| Veralox Therapeutics Inc | 021-405399 | Director | 14.4 M of 22.8 M |
||
| I2O Therapeutics Inc | 021-381826 | Director | 0.6 M of 0.6 M |
||
| I2O Therapeutics Inc | 021-363487 | Director | 3.2 M of 3.2 M |
||